~~<i id='C672AA0733'><strike id='C672AA0733'><tt id='C672AA0733'><pre id='C672AA0733'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

knowledge

author：focus 2025-09-30 19:25:26 - browse：49

JOHNSON & JOHNSON HEADQUARTERS — Daniel Hulshizer/AP

Eight months into his tenure, Johnson & Johnson’s R&D chief is putting a big emphasis on medicines for cancer, treatment-resistant depression, and autoimmune disease.

To sharpen that focus, R&D chief John Reed told STAT that the company is de-emphasizing two areas that have been mainstays for the drug and medical device giant: infectious disease and vaccines, as well as medicines targeting kidney disease and rare eye conditions.

The disclosures were made in an interview ahead of an investor meeting Reed is leading Tuesday aimed at generating excitement about the company’s research and development efforts.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： The Karikó problem: Lessons for funding basic research

entertainment

leisure time

explore

knowledge

explore

RickSlayman,holdinghandswithhispartner,Faren,poseswithmembersofhisMassachusettsGeneralHospitalmedica

WSS

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

CDC picks Alphabet's Verily for wasterwater surveillance contract

Stop Congress from blocking public access to science

H5N1 bird flu: what we're starting to learn about infection in cows

Telehealth startups turn to complex chronic diseases

Wikipedia

knowledge

entertainment

In age of alternative facts, a scholarly course on calling out crap

Flu, Covid vaccination rates decline, new survey data show

Medicare details structure of new drug price negotiation program

IVG is promising — but it won’t replace IVF quite yet

Sports medicine is finally prioritizing gender equality

Google says AlphaFold 3 can map a vast universe of biomolecules

After affirmative action ruling, medical educators look to 'holistic review'

Use wet bulb globe temperature, not heat index, to protect workers

Apple is now the first public company to be valued at $3 trillion

H5N1 communication has been strictly for the birds

leisure time

Bird flu outbreak in cows is latest avian flu curveball

The stability of $0 premiums in Medicare Advantage

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Brain worms: The science behind RFK Jr.'s parasitic infection

CRISPR base editing slashes cholesterol levels in monkeys

Making AI in medicine accessible to smaller, and rural hospitals

explore

knowledge

knowledge

explore